Notice Information
Notice Title
NHS Framework for the North of England, Branded Medicine
Notice Description
Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599
- Publication Source
- Contracts Finder
- Latest Notice
- https://www.contractsfinder.service.gov.uk/Notice/521ac6ee-777d-4ac4-8c5c-88045d5101fd
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure (above threshold)
- Tender Suitability
- SME
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £431,836,170 £100M-£1B
- Lots Value
- Not specified
- Awards Value
- £238,913,892 £100M-£1B
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 8 Aug 20232 years ago
- Submission Deadline
- 20 Oct 2021Expired
- Future Notice Date
- Not specified
- Award Date
- 7 Feb 20224 years ago
- Contract Period
- 1 Mar 2022 - 29 Feb 2024 2-3 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Not Specified
- Awards Status
- Active
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- RUNCORN
- Postcode
- WA7 2ES
- Post Town
- Warrington
- Country
- England
-
- Major Region (ITL 1)
- TLD North West (England)
- Basic Region (ITL 2)
- TLD7 Merseyside
- Small Region (ITL 3)
- TLD71 East Merseyside
- Delivery Location
- TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
-
- Local Authority
- Halton
- Electoral Ward
- Halton Lea
- Westminster Constituency
- Runcorn and Helsby
Further Information
Notice Documents
-
https://www.contractsfinder.service.gov.uk/Notice/521ac6ee-777d-4ac4-8c5c-88045d5101fd
8th August 2023 - Awarded contract notice on Contracts Finder -
https://www.contractsfinder.service.gov.uk/Notice/4e1189ae-e35a-4e20-a372-9d94847b46e3
15th July 2022 - Awarded contract notice on Contracts Finder -
https://www.contractsfinder.service.gov.uk/Notice/484b6e5e-50cb-4000-bdd3-ebf21ebdc232
1st March 2022 - Awarded contract notice on Contracts Finder -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Iso2/JUvAXEmjfS6f.mMOhTbVfIHEXs5HDHgSPuYrNIpo6XY
022928-2021 - FTS Contract Notice for CM_PHR_20_5600 -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnp/Xxwt6Xq_QWObNFnX4EoxJMUc_XbDGhXCKHrDE9qgZRE
Document No.10 Participating Authorities -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnq/k6sG9mcV2GkckTEI1To4GrwIUSpmgDNrh93hLpFGvbY
Parties appointed to the framework agreement -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnx/kOVRqTlgfxNepxyyU.B61imwHnc_UAO6QPbxYotDQaw
03. Framework Agreement and Terms and Conditions (1) -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isne/YID087kO.nMwTyYG2SOwhCawP2nL9HGlEjmt1ulNxo0
CM_PHR_20_5600_05 - Midlands and East Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isni/7TSKOEPze045lwL2BjsYIf89RcESghZ_8jvRhywstRM
CM_PHR_20_5600_02 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isno/xRBdJdiAS85GPqlCrT8Ogdj.rQZyf7EZWacC6sWPPLA
CM_PHR_20_5600_04 - London Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnn/Cry_SEgf23Qx_MviISVwJ1hSAtxWyJz_fYd2hj7gUnI
CM_PHR_20_5600_03 - South of England Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi -
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnd/vtfa5O1MSUvyM6xpc3N0_MZitxwYjXFxC73R7ldCpo8
CM_PHR_20_5600_01 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule -
https://www.contractsfinder.service.gov.uk/Notice/Attachment/e20ae3df-a776-4a0a-8b63-45dd0baa2c90
022928-2021 - FTS Contract Notice for CM_PHR_20_5600 -
https://www.contractsfinder.service.gov.uk/Notice/Attachment/c73000ad-5873-4fa6-998d-f1b1680a6fae
Document No.10 Participating Authorities -
https://www.contractsfinder.service.gov.uk/Notice/Attachment/8f0efa68-d252-42b4-8ab5-b3ffe61a594d
Parties appointed to the framework agreement -
https://www.contractsfinder.service.gov.uk/Notice/Attachment/7f20c186-583f-4271-950e-2170371a94bb
03. Framework Agreement and Terms and Conditions (1) -
https://www.contractsfinder.service.gov.uk/Notice/Attachment/fd34110c-317a-47d2-82a0-84fde45e206a
CM_PHR_20_5600_05 - Midlands and East Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi -
https://www.contractsfinder.service.gov.uk/Notice/Attachment/301f5cb5-7fbd-4db5-b846-a17077ea0787
CM_PHR_20_5600_02 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule -
https://www.contractsfinder.service.gov.uk/Notice/Attachment/efd44b98-6e0d-4088-a099-bfe11bfc196c
CM_PHR_20_5600_04 - London Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi -
https://www.contractsfinder.service.gov.uk/Notice/Attachment/bc00f9a2-975c-4a3c-9f60-937d2142fd4d
CM_PHR_20_5600_03 - South of England Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi -
https://www.contractsfinder.service.gov.uk/Notice/Attachment/23a80d8b-f7d3-46f2-8cc3-9741776de433
CM_PHR_20_5600_01 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599-2023-08-08T17:07:26+01:00",
"date": "2023-08-08T17:07:26+01:00",
"ocid": "ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599",
"language": "en",
"initiationType": "tender",
"tender": {
"id": "CF-0634100D0O000000rwimUAA",
"title": "NHS Framework for the North of England, Branded Medicine",
"description": "Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi(r)), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"postalCode": "WA7 2ES"
},
{
"region": "East Midlands",
"countryName": "United Kingdom"
},
{
"region": "East of England",
"countryName": "United Kingdom"
},
{
"region": "London",
"countryName": "United Kingdom"
},
{
"region": "North East",
"countryName": "United Kingdom"
},
{
"region": "North West",
"countryName": "United Kingdom"
},
{
"region": "South East",
"countryName": "United Kingdom"
},
{
"region": "South West",
"countryName": "United Kingdom"
},
{
"region": "West Midlands",
"countryName": "United Kingdom"
},
{
"region": "Yorkshire and the Humber",
"countryName": "United Kingdom"
},
{
"countryName": "Isle of Man"
},
{
"postalCode": "WA7 2ES"
},
{
"region": "East Midlands",
"countryName": "United Kingdom"
},
{
"region": "East of England",
"countryName": "United Kingdom"
},
{
"region": "London",
"countryName": "United Kingdom"
},
{
"region": "North East",
"countryName": "United Kingdom"
},
{
"region": "North West",
"countryName": "United Kingdom"
},
{
"region": "South East",
"countryName": "United Kingdom"
},
{
"region": "South West",
"countryName": "United Kingdom"
},
{
"region": "West Midlands",
"countryName": "United Kingdom"
},
{
"region": "Yorkshire and the Humber",
"countryName": "United Kingdom"
},
{
"countryName": "Isle of Man"
},
{
"postalCode": "WA7 2ES"
},
{
"region": "East Midlands",
"countryName": "United Kingdom"
},
{
"region": "East of England",
"countryName": "United Kingdom"
},
{
"region": "London",
"countryName": "United Kingdom"
},
{
"region": "North East",
"countryName": "United Kingdom"
},
{
"region": "North West",
"countryName": "United Kingdom"
},
{
"region": "South East",
"countryName": "United Kingdom"
},
{
"region": "South West",
"countryName": "United Kingdom"
},
{
"region": "West Midlands",
"countryName": "United Kingdom"
},
{
"region": "Yorkshire and the Humber",
"countryName": "United Kingdom"
},
{
"countryName": "Isle of Man"
}
]
}
],
"value": {
"amount": 431836170,
"currency": "GBP"
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure (above threshold)",
"tenderPeriod": {
"endDate": "2021-10-20T13:00:00+01:00"
},
"contractPeriod": {
"startDate": "2022-03-01T00:00:00Z",
"endDate": "2024-02-29T23:59:59Z"
},
"suitability": {
"sme": true,
"vcse": false
},
"mainProcurementCategory": "goods"
},
"parties": [
{
"id": "GB-CFS-156282",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "2nd Floor Rutland House",
"locality": "Runcorn",
"postalCode": "WA7 2ES",
"countryName": "UK"
},
"contactPoint": {
"name": "Giorgie Rushton",
"email": "giorgie.rushton2@nhs.net"
},
"roles": [
"buyer"
]
},
{
"id": "GB-CFS-165045",
"name": "Thornton and Ross Ltd",
"identifier": {
"legalName": "Thornton and Ross Ltd"
},
"address": {
"streetAddress": ", Huddersfield"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-165041",
"name": "Janssen-Cilag Ltd",
"identifier": {
"legalName": "Janssen-Cilag Ltd"
},
"address": {
"streetAddress": ", High Wycombe"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183730",
"name": "Biogen",
"identifier": {
"legalName": "Biogen"
},
"address": {
"streetAddress": ", Maidenhead"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183745",
"name": "Merck Serono Limited",
"identifier": {
"legalName": "Merck Serono Limited"
},
"address": {
"streetAddress": ", Feltham"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183743",
"name": "Celltrion Healthcare United Kingdom Limited",
"identifier": {
"legalName": "Celltrion Healthcare United Kingdom Limited"
},
"address": {
"streetAddress": ", Slough"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183746",
"name": "Bristol Myers Squibb",
"identifier": {
"legalName": "Bristol Myers Squibb"
},
"address": {
"streetAddress": ", Uxbridge"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-165038",
"name": "AstraZeneca",
"identifier": {
"legalName": "AstraZeneca"
},
"address": {
"streetAddress": ", Luton"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183729",
"name": "UL Global Pharma",
"identifier": {
"legalName": "UL Global Pharma"
},
"address": {
"streetAddress": ", Hertfordshire"
},
"details": {
"scale": "sme"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-198842",
"name": "GlaxoSmithKline UK Limited",
"identifier": {
"legalName": "GlaxoSmithKline UK Limited"
},
"address": {
"streetAddress": ", London"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183739",
"name": "Roche Products Ltd",
"identifier": {
"legalName": "Roche Products Ltd"
},
"address": {
"streetAddress": ", Garden City"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183733",
"name": "Bayer Ltd",
"identifier": {
"legalName": "Bayer Ltd"
},
"address": {
"streetAddress": ", Reading"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183732",
"name": "Merck Sharpe & Dohme (UK) Limited",
"identifier": {
"legalName": "Merck Sharpe & Dohme (UK) Limited"
},
"address": {
"streetAddress": ", London"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183738",
"name": "Pfizer Ltd",
"identifier": {
"legalName": "Pfizer Ltd"
},
"address": {
"streetAddress": ", Kent"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183727",
"name": "Accord-UK Ltd",
"identifier": {
"legalName": "Accord-UK Ltd"
},
"address": {
"streetAddress": ", Devon"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183735",
"name": "Novo Nordisk",
"identifier": {
"legalName": "Novo Nordisk"
},
"address": {
"streetAddress": ", Gatwick"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-165043",
"name": "Sandoz Ltd",
"identifier": {
"legalName": "Sandoz Ltd"
},
"address": {
"streetAddress": ", Camberley"
},
"details": {
"scale": "sme"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183734",
"name": "Napp Pharmaceuticals Ltd",
"identifier": {
"legalName": "Napp Pharmaceuticals Ltd"
},
"address": {
"streetAddress": ", Cambridge"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183747",
"name": "Eli Lilly & Company Ltd",
"identifier": {
"legalName": "Eli Lilly & Company Ltd"
},
"address": {
"streetAddress": ", Basingstoke"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183755",
"name": "Ipsen",
"identifier": {
"legalName": "Ipsen"
},
"address": {
"streetAddress": ", Slough"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183731",
"name": "Amgen Ltd",
"identifier": {
"legalName": "Amgen Ltd"
},
"address": {
"streetAddress": ", Cambridge"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183752",
"name": "Aventis Pharma ltd t/a Sanofi",
"identifier": {
"legalName": "Aventis Pharma ltd t/a Sanofi"
},
"address": {
"streetAddress": ", Reading"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-198845",
"name": "UCB Pharma Ltd",
"identifier": {
"legalName": "UCB Pharma Ltd"
},
"address": {
"streetAddress": ", Slough"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-165044",
"name": "Teva UK Limited",
"identifier": {
"legalName": "Teva UK Limited"
},
"address": {
"streetAddress": ", Castleford"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-165046",
"name": "Zentiva Pharma UK Ltd",
"identifier": {
"legalName": "Zentiva Pharma UK Ltd"
},
"address": {
"streetAddress": ", London"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183757",
"name": "CST Pharma Limited",
"identifier": {
"legalName": "CST Pharma Limited"
},
"address": {
"streetAddress": ", Walsall"
},
"details": {
"scale": "sme"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183750",
"name": "Takeda UK Ltd",
"identifier": {
"legalName": "Takeda UK Ltd"
},
"address": {
"streetAddress": ", London"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183740",
"name": "Mylan",
"identifier": {
"legalName": "Mylan"
},
"address": {
"streetAddress": ", Barnet"
},
"details": {
"scale": "sme"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183758",
"name": "Gilead Sciences Limited",
"identifier": {
"legalName": "Gilead Sciences Limited"
},
"address": {
"streetAddress": ", Holborn"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-183742",
"name": "Organon Pharmaceuticals UK Ltd",
"identifier": {
"legalName": "Organon Pharmaceuticals UK Ltd"
},
"address": {
"streetAddress": ", London"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-CFS-213225",
"name": "Gedeon Richter UK Ltd",
"identifier": {
"legalName": "Gedeon Richter UK Ltd"
},
"address": {
"streetAddress": ", Maida Vale - London"
},
"details": {
"scale": "sme"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-183744",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)",
"identifier": {
"legalName": "Sobi (Swedish Orphan Biovitrum Ltd)"
},
"address": {
"streetAddress": ", Cambridgeshire"
},
"details": {
"scale": "sme"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254546",
"name": "Janssen-Cilag Ltd",
"identifier": {
"legalName": "Janssen-Cilag Ltd"
},
"address": {
"streetAddress": "50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, High Wycombe"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254547",
"name": "Biogen",
"identifier": {
"legalName": "Biogen"
},
"address": {
"streetAddress": "Innovation House 70 Norden Road, 70 Norden Road, Maidenhead, Berkshire, Maidenhead"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254548",
"name": "Merck Serono Limited",
"identifier": {
"legalName": "Merck Serono Limited"
},
"address": {
"streetAddress": "5 New Square, Bedfont Lakes Business Park, Feltham, Feltham"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254549",
"name": "Celltrion Healthcare United Kingdom Limited",
"identifier": {
"legalName": "Celltrion Healthcare United Kingdom Limited"
},
"address": {
"streetAddress": "The Switch 1-7 The Grove, 1-7 The Grove, Slough, Slough"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254550",
"name": "Bristol Myers Squibb",
"identifier": {
"legalName": "Bristol Myers Squibb"
},
"address": {
"streetAddress": "Arc Uxbridge Sanderson Road, New Denham, Denham, Buckinghamshire, England, Uxbridge"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254551",
"name": "AstraZeneca",
"identifier": {
"legalName": "AstraZeneca"
},
"address": {
"streetAddress": "1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge,, Luton"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254552",
"name": "GlaxoSmithKline UK Limited",
"identifier": {
"legalName": "GlaxoSmithKline UK Limited"
},
"address": {
"streetAddress": "980 Great West Road, Brentford, Middlesex, London"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254553",
"name": "Roche Products Ltd",
"identifier": {
"legalName": "Roche Products Ltd"
},
"address": {
"streetAddress": "6 Falcon Way, Shire Park, Welwyn Garden City, Garden City"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254554",
"name": "Bayer Ltd",
"identifier": {
"legalName": "Bayer Ltd"
},
"address": {
"streetAddress": "400 South Oak Way, Reading, Berkshire, Reading"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254555",
"name": "Merck Sharpe & Dohme (UK) Limited",
"identifier": {
"legalName": "Merck Sharpe & Dohme (UK) Limited"
},
"address": {
"streetAddress": "120 Moorgate, London, London"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254556",
"name": "Pfizer Ltd",
"identifier": {
"legalName": "Pfizer Ltd"
},
"address": {
"streetAddress": "Pfizer Limited, Ramsgate Road, Sandwich, Kent, Kent"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254557",
"name": "Accord-UK Ltd",
"identifier": {
"legalName": "Accord-UK Ltd"
},
"address": {
"streetAddress": "Whiddon Valley, Barnstaple, Devon, EX32 8NS, Devon, EX32 8NS"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254558",
"name": "Novo Nordisk",
"identifier": {
"legalName": "Novo Nordisk"
},
"address": {
"streetAddress": "3 City Place, Beehive Ring Road, Gatwick, West Sussex, Gatwick"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254559",
"name": "Napp Pharmaceuticals Ltd",
"identifier": {
"legalName": "Napp Pharmaceuticals Ltd"
},
"address": {
"streetAddress": "Unit 196 Cambridge Science Park, Milton Road, Cambridge, Cambridge"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254560",
"name": "Eli Lilly & Company Ltd",
"identifier": {
"legalName": "Eli Lilly & Company Ltd"
},
"address": {
"streetAddress": "Lilly House, Priestley Road, Basingstoke, Hampshire, Basingstoke"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254561",
"name": "Ipsen",
"identifier": {
"legalName": "Ipsen"
},
"address": {
"streetAddress": "190 Bath Road, Slough, Berkshire, Slough"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254562",
"name": "Amgen Ltd",
"identifier": {
"legalName": "Amgen Ltd"
},
"address": {
"streetAddress": "240 Science Park Milton Road Cambridge, Cambridge"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254563",
"name": "Aventis Pharma ltd t/a Sanofi",
"identifier": {
"legalName": "Aventis Pharma ltd t/a Sanofi"
},
"address": {
"streetAddress": "410 Thames Valley Park Drive, Reading, Berkshire, Reading"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254564",
"name": "CST Pharma Limited",
"identifier": {
"legalName": "CST Pharma Limited"
},
"address": {
"streetAddress": "Westate Park, Units 5-7, Tintagel Way, Aldridge, Walsall, Walsall"
},
"details": {
"scale": "sme"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254565",
"name": "Mylan",
"identifier": {
"legalName": "Mylan"
},
"address": {
"streetAddress": "Building 4, Trident Place, Mosquito Way, Hatfield, Hertfordshire,, Barnet"
},
"details": {
"scale": "sme"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254566",
"name": "Gilead Sciences Limited",
"identifier": {
"legalName": "Gilead Sciences Limited"
},
"address": {
"streetAddress": "280 High Holborn, London, Holborn"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254567",
"name": "Organon Pharmaceuticals UK Ltd",
"identifier": {
"legalName": "Organon Pharmaceuticals UK Ltd"
},
"address": {
"streetAddress": "Hertford Road, Hoddesdon, Hertfordshire, London"
},
"details": {
"scale": "large"
},
"roles": [
"supplier"
]
},
{
"id": "GB-CFS-254568",
"name": "Gedeon Richter UK Ltd",
"identifier": {
"legalName": "Gedeon Richter UK Ltd"
},
"address": {
"streetAddress": "127 Shirland Road, London, Maida Vale - London"
},
"details": {
"scale": "sme"
},
"roles": [
"supplier"
]
}
],
"buyer": {
"id": "GB-CFS-156282",
"name": "NHS England"
},
"awards": [
{
"id": "ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599-1",
"status": "active",
"date": "2022-02-07T00:00:00Z",
"datePublished": "2022-03-01T12:24:13Z",
"value": {
"amount": 238913892,
"currency": "GBP"
},
"suppliers": [
{
"id": "GB-CFS-165045",
"name": "Thornton and Ross Ltd"
},
{
"id": "GB-CFS-165041",
"name": "Janssen-Cilag Ltd"
},
{
"id": "GB-CFS-183730",
"name": "Biogen"
},
{
"id": "GB-CFS-183745",
"name": "Merck Serono Limited"
},
{
"id": "GB-CFS-183743",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-CFS-183746",
"name": "Bristol Myers Squibb"
},
{
"id": "GB-CFS-165038",
"name": "AstraZeneca"
},
{
"id": "GB-CFS-183729",
"name": "UL Global Pharma"
},
{
"id": "GB-CFS-198842",
"name": "GlaxoSmithKline UK Limited"
},
{
"id": "GB-CFS-183739",
"name": "Roche Products Ltd"
},
{
"id": "GB-CFS-183733",
"name": "Bayer Ltd"
},
{
"id": "GB-CFS-183732",
"name": "Merck Sharpe & Dohme (UK) Limited"
},
{
"id": "GB-CFS-183738",
"name": "Pfizer Ltd"
},
{
"id": "GB-CFS-183727",
"name": "Accord-UK Ltd"
},
{
"id": "GB-CFS-183735",
"name": "Novo Nordisk"
},
{
"id": "GB-CFS-165043",
"name": "Sandoz Ltd"
},
{
"id": "GB-CFS-183734",
"name": "Napp Pharmaceuticals Ltd"
},
{
"id": "GB-CFS-183747",
"name": "Eli Lilly & Company Ltd"
},
{
"id": "GB-CFS-183755",
"name": "Ipsen"
},
{
"id": "GB-CFS-183731",
"name": "Amgen Ltd"
},
{
"id": "GB-CFS-183752",
"name": "Aventis Pharma ltd t/a Sanofi"
},
{
"id": "GB-CFS-198845",
"name": "UCB Pharma Ltd"
},
{
"id": "GB-CFS-165044",
"name": "Teva UK Limited"
},
{
"id": "GB-CFS-165046",
"name": "Zentiva Pharma UK Ltd"
},
{
"id": "GB-CFS-183757",
"name": "CST Pharma Limited"
},
{
"id": "GB-CFS-183750",
"name": "Takeda UK Ltd"
},
{
"id": "GB-CFS-183740",
"name": "Mylan"
},
{
"id": "GB-CFS-183758",
"name": "Gilead Sciences Limited"
},
{
"id": "GB-CFS-183742",
"name": "Organon Pharmaceuticals UK Ltd"
},
{
"id": "GB-CFS-213225",
"name": "Gedeon Richter UK Ltd"
},
{
"id": "GB-CFS-183744",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)"
}
],
"contractPeriod": {
"startDate": "2022-03-01T00:00:00Z",
"endDate": "2024-02-29T23:59:59Z"
},
"documents": [
{
"id": "1",
"documentType": "awardNotice",
"description": "Awarded contract notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/484b6e5e-50cb-4000-bdd3-ebf21ebdc232",
"datePublished": "2022-03-01T12:24:13Z",
"format": "text/html",
"language": "en"
}
]
},
{
"id": "ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599-2",
"status": "active",
"date": "2022-02-07T00:00:00Z",
"datePublished": "2022-07-15T10:03:15+01:00",
"value": {
"amount": 238913892,
"currency": "GBP"
},
"suppliers": [
{
"id": "GB-CFS-165045",
"name": "Thornton and Ross Ltd"
},
{
"id": "GB-CFS-165041",
"name": "Janssen-Cilag Ltd"
},
{
"id": "GB-CFS-183730",
"name": "Biogen"
},
{
"id": "GB-CFS-183745",
"name": "Merck Serono Limited"
},
{
"id": "GB-CFS-183743",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-CFS-183746",
"name": "Bristol Myers Squibb"
},
{
"id": "GB-CFS-165038",
"name": "AstraZeneca"
},
{
"id": "GB-CFS-183729",
"name": "UL Global Pharma"
},
{
"id": "GB-CFS-198842",
"name": "GlaxoSmithKline UK Limited"
},
{
"id": "GB-CFS-183739",
"name": "Roche Products Ltd"
},
{
"id": "GB-CFS-183733",
"name": "Bayer Ltd"
},
{
"id": "GB-CFS-183732",
"name": "Merck Sharpe & Dohme (UK) Limited"
},
{
"id": "GB-CFS-183738",
"name": "Pfizer Ltd"
},
{
"id": "GB-CFS-183727",
"name": "Accord-UK Ltd"
},
{
"id": "GB-CFS-183735",
"name": "Novo Nordisk"
},
{
"id": "GB-CFS-165043",
"name": "Sandoz Ltd"
},
{
"id": "GB-CFS-183734",
"name": "Napp Pharmaceuticals Ltd"
},
{
"id": "GB-CFS-183747",
"name": "Eli Lilly & Company Ltd"
},
{
"id": "GB-CFS-183755",
"name": "Ipsen"
},
{
"id": "GB-CFS-183731",
"name": "Amgen Ltd"
},
{
"id": "GB-CFS-183752",
"name": "Aventis Pharma ltd t/a Sanofi"
},
{
"id": "GB-CFS-198845",
"name": "UCB Pharma Ltd"
},
{
"id": "GB-CFS-165044",
"name": "Teva UK Limited"
},
{
"id": "GB-CFS-165046",
"name": "Zentiva Pharma UK Ltd"
},
{
"id": "GB-CFS-183757",
"name": "CST Pharma Limited"
},
{
"id": "GB-CFS-183750",
"name": "Takeda UK Ltd"
},
{
"id": "GB-CFS-183740",
"name": "Mylan"
},
{
"id": "GB-CFS-183758",
"name": "Gilead Sciences Limited"
},
{
"id": "GB-CFS-183742",
"name": "Organon Pharmaceuticals UK Ltd"
},
{
"id": "GB-CFS-213225",
"name": "Gedeon Richter UK Ltd"
},
{
"id": "GB-CFS-183744",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)"
}
],
"contractPeriod": {
"startDate": "2022-03-01T00:00:00Z",
"endDate": "2024-02-29T23:59:59Z"
},
"documents": [
{
"id": "2",
"documentType": "awardNotice",
"description": "Awarded contract notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/4e1189ae-e35a-4e20-a372-9d94847b46e3",
"datePublished": "2022-07-15T10:03:15+01:00",
"format": "text/html",
"language": "en"
},
{
"id": "3",
"description": "022928-2021 - FTS Contract Notice for CM_PHR_20_5600",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Iso2/JUvAXEmjfS6f.mMOhTbVfIHEXs5HDHgSPuYrNIpo6XY"
},
{
"id": "4",
"description": "Document No.10 Participating Authorities",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnp/Xxwt6Xq_QWObNFnX4EoxJMUc_XbDGhXCKHrDE9qgZRE"
},
{
"id": "5",
"description": "Parties appointed to the framework agreement",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnq/k6sG9mcV2GkckTEI1To4GrwIUSpmgDNrh93hLpFGvbY"
},
{
"id": "6",
"description": "03. Framework Agreement and Terms and Conditions (1)",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnx/kOVRqTlgfxNepxyyU.B61imwHnc_UAO6QPbxYotDQaw"
},
{
"id": "7",
"description": "CM_PHR_20_5600_05 - Midlands and East Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isne/YID087kO.nMwTyYG2SOwhCawP2nL9HGlEjmt1ulNxo0"
},
{
"id": "8",
"description": "CM_PHR_20_5600_02 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isni/7TSKOEPze045lwL2BjsYIf89RcESghZ_8jvRhywstRM"
},
{
"id": "9",
"description": "CM_PHR_20_5600_04 - London Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isno/xRBdJdiAS85GPqlCrT8Ogdj.rQZyf7EZWacC6sWPPLA"
},
{
"id": "10",
"description": "CM_PHR_20_5600_03 - South of England Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnn/Cry_SEgf23Qx_MviISVwJ1hSAtxWyJz_fYd2hj7gUnI"
},
{
"id": "11",
"description": "CM_PHR_20_5600_01 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule",
"url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Isnd/vtfa5O1MSUvyM6xpc3N0_MZitxwYjXFxC73R7ldCpo8"
}
]
},
{
"id": "ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599-3",
"status": "active",
"date": "2022-02-07T00:00:00Z",
"datePublished": "2023-08-08T17:07:21+01:00",
"value": {
"amount": 238913892,
"currency": "GBP"
},
"suppliers": [
{
"id": "GB-CFS-165045",
"name": "Thornton and Ross Ltd"
},
{
"id": "GB-CFS-254546",
"name": "Janssen-Cilag Ltd"
},
{
"id": "GB-CFS-254547",
"name": "Biogen"
},
{
"id": "GB-CFS-254548",
"name": "Merck Serono Limited"
},
{
"id": "GB-CFS-254549",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-CFS-254550",
"name": "Bristol Myers Squibb"
},
{
"id": "GB-CFS-254551",
"name": "AstraZeneca"
},
{
"id": "GB-CFS-183729",
"name": "UL Global Pharma"
},
{
"id": "GB-CFS-254552",
"name": "GlaxoSmithKline UK Limited"
},
{
"id": "GB-CFS-254553",
"name": "Roche Products Ltd"
},
{
"id": "GB-CFS-254554",
"name": "Bayer Ltd"
},
{
"id": "GB-CFS-254555",
"name": "Merck Sharpe & Dohme (UK) Limited"
},
{
"id": "GB-CFS-254556",
"name": "Pfizer Ltd"
},
{
"id": "GB-CFS-254557",
"name": "Accord-UK Ltd"
},
{
"id": "GB-CFS-254558",
"name": "Novo Nordisk"
},
{
"id": "GB-CFS-165043",
"name": "Sandoz Ltd"
},
{
"id": "GB-CFS-254559",
"name": "Napp Pharmaceuticals Ltd"
},
{
"id": "GB-CFS-254560",
"name": "Eli Lilly & Company Ltd"
},
{
"id": "GB-CFS-254561",
"name": "Ipsen"
},
{
"id": "GB-CFS-254562",
"name": "Amgen Ltd"
},
{
"id": "GB-CFS-254563",
"name": "Aventis Pharma ltd t/a Sanofi"
},
{
"id": "GB-CFS-198845",
"name": "UCB Pharma Ltd"
},
{
"id": "GB-CFS-165044",
"name": "Teva UK Limited"
},
{
"id": "GB-CFS-165046",
"name": "Zentiva Pharma UK Ltd"
},
{
"id": "GB-CFS-254564",
"name": "CST Pharma Limited"
},
{
"id": "GB-CFS-183750",
"name": "Takeda UK Ltd"
},
{
"id": "GB-CFS-254565",
"name": "Mylan"
},
{
"id": "GB-CFS-254566",
"name": "Gilead Sciences Limited"
},
{
"id": "GB-CFS-254567",
"name": "Organon Pharmaceuticals UK Ltd"
},
{
"id": "GB-CFS-254568",
"name": "Gedeon Richter UK Ltd"
},
{
"id": "GB-CFS-183744",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)"
}
],
"contractPeriod": {
"startDate": "2022-03-01T00:00:00Z",
"endDate": "2024-02-29T23:59:59Z"
},
"documents": [
{
"id": "12",
"documentType": "awardNotice",
"description": "Awarded contract notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/521ac6ee-777d-4ac4-8c5c-88045d5101fd",
"datePublished": "2023-08-08T17:07:21+01:00",
"format": "text/html",
"language": "en"
},
{
"id": "13",
"description": "022928-2021 - FTS Contract Notice for CM_PHR_20_5600",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/e20ae3df-a776-4a0a-8b63-45dd0baa2c90",
"format": "application/pdf"
},
{
"id": "14",
"description": "Document No.10 Participating Authorities",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/c73000ad-5873-4fa6-998d-f1b1680a6fae",
"format": "application/vnd.ms-excel"
},
{
"id": "15",
"description": "Parties appointed to the framework agreement",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/8f0efa68-d252-42b4-8ab5-b3ffe61a594d",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document"
},
{
"id": "16",
"description": "03. Framework Agreement and Terms and Conditions (1)",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/7f20c186-583f-4271-950e-2170371a94bb",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document"
},
{
"id": "17",
"description": "CM_PHR_20_5600_05 - Midlands and East Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/fd34110c-317a-47d2-82a0-84fde45e206a",
"format": "application/pdf"
},
{
"id": "18",
"description": "CM_PHR_20_5600_02 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/301f5cb5-7fbd-4db5-b846-a17077ea0787",
"format": "application/pdf"
},
{
"id": "19",
"description": "CM_PHR_20_5600_04 - London Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/efd44b98-6e0d-4088-a099-bfe11bfc196c",
"format": "application/pdf"
},
{
"id": "20",
"description": "CM_PHR_20_5600_03 - South of England Proprietary Proprietary Medicines, Insulin Aspart Biosimilar, Trurapi",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/bc00f9a2-975c-4a3c-9f60-937d2142fd4d",
"format": "application/pdf"
},
{
"id": "21",
"description": "CM_PHR_20_5600_01 - NHS Framework for the NOFE, Branded Medicines - Transparency Award Schedule",
"url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/23a80d8b-f7d3-46f2-8cc3-9741776de433",
"format": "application/pdf"
}
]
}
]
}